Influence of the timing of blood transfusion on experimental tumor growth.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 8474239)

Published in J Surg Res on March 01, 1993

Authors

D M Francis1, G J Clunie

Author Affiliations

1: Department of Surgery, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia.

Articles by these authors

(truncated to the top 100)

What is the future of the hospital system? Med J Aust (1997) 2.72

An early pregnancy factor detected in human serum by the rosette inhibition test. Lancet (1977) 1.26

Immunosuppression detected in pregnant mice by rosette inhibition test. Nature (1974) 1.25

Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery (1980) 1.24

Studies of the rosette inhibition test in pregnant mice: evidence of immunosuppression? Proc R Soc Lond B Biol Sci (1976) 1.23

Restoration of renal function by arterial surgery. Lancet (1974) 1.21

Retained biliary calculi: removal by a simple non-operative technique. Ann Surg (1974) 1.20

Prolongation of canine renal allograft survival with antilymphocytic serum. Transplantation (1968) 1.16

Early pregnancy factor is immunosuppressive. Nature (1979) 1.09

Autotransplantation of the kidney in the treatment of renovascular hypertension. Surgery (1971) 1.08

Acceleration of B16 melanoma growth in mice after blood transfusion. Surgery (1987) 1.01

Detection and separation of two serum factors responsible for depression of lymphocyte activity in pregnancy. Clin Exp Immunol (1978) 1.00

Kidney preservation for transportation. Function of 29 human-cadaver kidneys preserved with an intracellular perfusate. N Engl J Med (1971) 0.94

Intermittent haemodialysis: insertion and care of the silastic-teflon cannula. Br Med J (1967) 0.93

Splenectomy for anaemia in patients on regular haemodialysis. Lancet (1971) 0.93

An integrated service for the treatment of irreversible renal failure. Med J Aust (1971) 0.91

Detection of early pregnancy in sheep by the rosette inhibition test. J Reprod Fertil (1979) 0.88

Review of keratinocyte culture techniques: problems of growing skin. Aust N Z J Surg (1989) 0.86

Renovascular hypertension: the place of renal autotransplantation. Br J Surg (1973) 0.86

The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients. Br J Cancer (1975) 0.85

Electrocardiographic monitoring of cardiac transplants in mice. Cardiovasc Res (1988) 0.85

Antilymphocyte serum: studies of the specificity of the rosette-inhibiting antibody in rabbit anti-mouse ALS. Aust J Exp Biol Med Sci (1976) 0.83

Inhibition of whole blood antibody dependent cellular cytotoxicity by heat aggregated human IgG. J Immunol Methods (1981) 0.83

Correlation between ADCC resistance to in vitro steroid and renal allograft failure. Transplant Proc (1981) 0.81

A single dose of UV radiation suppresses delayed type hypersensitivity responses to alloantigens and prolongs heart allograft survival in mice. Immunol Cell Biol (1989) 0.81

Hyperparathyroid crisis. Br J Surg (1967) 0.81

Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy. Cancer Res (1977) 0.80

Kidney transplantation from living related donors: a 19-year experience. Med J Aust (1993) 0.80

Increased risk of rejection in renal transplant recipients with in vitro cyclosporin-resistant lymphoid responses. Transplant Proc (1989) 0.80

The rosette inhibition test: technical considerations. Transplantation (1972) 0.79

Results of surgical treatment of renovascular hypertension. Med J Aust (1975) 0.79

Exchange of cadaveric kidneys for transplantation in Australia and New Zealand. Aust N Z J Med (1979) 0.79

Production and assay of dog, pig and goat heterologous anti-rabbit lymphocyte serum. Clin Exp Immunol (1973) 0.78

Bilateral renal artery aneurysms: in-situ and extracorporeal repair. Aust N Z J Surg (1977) 0.78

Further experience with an external ureterovesical anastomosis in renal transplantation. Aust N Z J Surg (1979) 0.78

In-vitro leucocyte migration in renal transplantation. Med J Aust (1974) 0.78

Effects of cyclosporin A, antilymphocyte serum and donor-specific transfusions on murine delayed-type hypersensitivity and skin graft survival. Int Arch Allergy Appl Immunol (1986) 0.78

A rabbit model for heterotopic cardiac transplantation. Transplantation (1990) 0.77

Extracorporeal shock-wave lithotripsy and the management of common bile-duct calculi. Med J Aust (1988) 0.77

The effect of operative ischemia in murine cardiac transplantation: isograft control studies. Surgery (1987) 0.77

Cadaver renal transplantation in children using low dose triple immunosuppression. Transplant Proc (1989) 0.77

Kidney preservation for transportation. Experimental analysis of optimal perfusate composition. Br J Surg (1972) 0.76

Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies. Transplant Proc (1987) 0.76

A test for early pregnancy in sheep. Res Vet Sci (1979) 0.76

Neck swellings which mimic branchial cysts in HIV-positive patients. Ann R Coll Surg Engl (1994) 0.75

Myocardial calcification. J Heart Transplant (1989) 0.75

Prostaglandin E1 and E2 suppression of in vitro lymphoid responses to alloantigen. Transplant Proc (1989) 0.75

Spontaneous renal allograft rupture: a disappearing phenomenon in the cyclosporine era? Aust N Z J Surg (1992) 0.75

Anti-T cell monoclonal antibodies for in vivo treatment of cardiac allograft rejection in mice. Transplant Proc (1989) 0.75

Synergistic prolongation of rabbit renal allograft survival by cyclosporine and a prostacyclin analogue. Transplant Proc (1992) 0.75

A technique for the in vitro culture of human parathyroid gland tissue. Aust N Z J Surg (1988) 0.75

Blood transfusion induction of immunosuppressant-resistant lymphoid populations in dialysis patients. Transplant Proc (1987) 0.75

Lymphoid resistant responses to in vitro immunosuppression in renal transplant recipients: increased incidence of refractory episodes. Transplant Proc (1988) 0.75

Wound infections presenting several years after successful renal transplantation. Transplant Proc (1988) 0.75

Intercity transfer of canine kidney allografts. Med J Aust (1971) 0.75

Increased frequency of kidney allograft rejection in recipients with cyclosporine and/or steroid-resistant lymphoid responses. Transplant Proc (1990) 0.75

Deletion of graft reactive cells by idarubicin-anti-CD8 (Ly-2.1) immunoconjugate: studies in the mouse heart graft model. Transplant Proc (1991) 0.75

Living-related and living-unrelated kidney transplantation using low-dose triple immunosuppression. Transplant Proc (1992) 0.75

A simplified klidney preservation system--development and initial results. Med J Aust (1973) 0.75

Variable rejection patterns of cultured keratinocyte allografts in the rabbit. Br J Plast Surg (1993) 0.75

Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin. Transplant Proc (1993) 0.75

Preoperative identification of high-risk recipients of first kidney transplants by in vitro lymphocyte resistance to immunosuppressive agents. Transplant Proc (1991) 0.75

Enhancement of rabbit cardiac allografts by third-party hepatocytes. Transplant Proc (1991) 0.75

Intermittent haemodialysis in the treatment of chronic renal failure. Nurs Mirror Midwives J (1966) 0.75

In vitro culture of disaggregated rabbit keratinocytes. Immunol Cell Biol (1990) 0.75

Vesico-ureteric reflux and lymphoid resistance to in vitro steroid: adverse risk factors for renal transplantation. Transplant Proc (1989) 0.75

Autotransplantation of the kidney. Br J Urol (1972) 0.75

Surgical training links between the United Kingdom and Australasia. Aust N Z J Surg (1993) 0.75

The place of the rosette inhibition test in the preparation and assay of antilymphocytic globulin. Aust N Z J Surg (1973) 0.75

Anti-T cell-specific immunoconjugates in mice: in vivo effects. Transplant Proc (1989) 0.75

Prevention of acute cyclosporine nephrotoxicity in rabbits with a prostacyclin analogue. Transplant Proc (1992) 0.75

Enhancement of rabbit skin allograft survival by pretransplant and peroperative hepatic antigen treatments. Transplant Proc (1990) 0.75

Cyclosporine A: graft survival and cardiotoxicity in murine cardiac allografts. Transplant Proc (1987) 0.75

Radiation oncology in Australia. Aust N Z J Surg (1990) 0.75

Adverse influence of recipient lymphoid resistance to in vitro immunosuppression on the outcome of kidney transplants. Transplantation (1988) 0.75

Cyclosporine dosage requirements for rabbit skin allograft enhancement due to perioperative blood transfusion and cyclosporine synergy. Transplant Proc (1987) 0.75

Abrogation of cyclosporine/transfusion-induced enhancement of rabbit skin allografts by increased cyclosporine dosage. Transplant Proc (1987) 0.75

Enhancement of renal allografts by simultaneous cyclosporine and donor-specific blood transfusion. Transplant Proc (1987) 0.75

In vitro analysis of the cation content of solutions for kidney storage. Cryobiology (1972) 0.75

The place of heterologous antilymphocytic globulin in renal transplantation. Med J Aust (1969) 0.75

Recurrent secondary hyperparathyroidism due to implanted parathyroid tissue: a case report. Aust N Z J Surg (1990) 0.75

Ethics and experimentation. Lancet (1970) 0.75

Surgical training in Queensland. Med J Aust (1973) 0.75

T suppressor cells induced by transfusions and cyclosporine. Studies in the murine cardiac allograft model. Transplantation (1990) 0.75

Suppression of canine renal allograft rejection with antilymphocyte serum. Aust N Z J Surg (1969) 0.75

In vitro estimates of biological potency of equine antihuman thymocyte globulin (ATGAM). Transplant Proc (1989) 0.75

Isograft and allograft control studies for murine cardiac transplantation. Transplant Proc (1987) 0.75

The new biology. Aust N Z J Surg (1988) 0.75

Model of orthotopic renal transplantation in the rabbit. Aust N Z J Surg (1990) 0.75

Mercurial diuretic protection of the ischemic kidney in the rat. Surg Forum (1966) 0.75

Cyclosporine-sparing influence of the synthetic PGE1 analogue enisoprost in rabbit cardiac allograft recipients. Transplant Proc (1992) 0.75

Immunosuppressive and cardiotoxic effects of cyclosporine in CBA mice. Transplantation (1989) 0.75

Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice. Transplantation (1993) 0.75

An in vitro comparison of the immunosuppressive potential of synthetic prostaglandin analogues. Transplant Proc (1991) 0.75

Kidney preservation for transportation. 5. Comparison of perfusates for hypothermic storage. Med J Aust (1971) 0.75

Exchange of cadaveric kidneys for transplantation. Med J Aust (1972) 0.75

Evaluation of simple methods for assessing renal ischemic injury. Surg Gynecol Obstet (1973) 0.75

Immunosuppression by anti-CD8 (Ly-2.1) MAb conjugated to idarubicin: studies in the mouse heart graft model. Transplant Proc (1990) 0.75

Kidney preservation for transportation. 6. A new perfusate applied to human cadaveric kidneys. Med J Aust (1971) 0.75

Cyclosporine regulation of blood transfusion sensitizing and enhancing potential in rabbit skin allograft recipients. Transplant Proc (1988) 0.75